Top Markets
#1 DeFiChain DeFiChain +1,198.24%
#2 Superfortune Superfortune +102.53%
#3 The Black Bull The Black Bull +88.66%
#4 V.I.T.R.I.O.L. Network V.I.T.R.I.O.L. Network +82.96%
#5 Alien Worlds Alien Worlds +73.06%
#6 Metaplex Metaplex +71.68%
#7 TokenOS AI TokenOS AI +63.39%
#8 Nexus Nexus +53.26%
#9 Magma Finance Magma Finance +44.02%
#10 Hamster Kombat Hamster Kombat +32.59%
Coin of the day
DeFiChain DeFiChain
Settings
Language
ENGLISH
Currency
USD
Theme
Virbac SA Virbac SA

Virbac SA

VIRP
Rank in Stocks #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Share Price
$393.80
Market Cap
$3.30B
Change (1 day)
0.15%
Change (1 year)
4.67%
Country
FR
Trade Virbac SA (VIRP)

Category

Healthcare
Number of shares outstanding for Virbac SA (VIRP)
Number of shares outstanding as of December 2025: 8.41M
According to Virbac SA latest financial reports and stock price the company's current number of shares outstanding is 8.41M. At the end of December 2023 the company had 8.44M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Virbac SA (VIRP) from 2002 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 8.41M 0.36%
2024 8.38M -0.67%
2023 8.44M -0.15%
2022 8.45M 0.01%
2021 8.45M 0.13%
2020 8.44M 0.06%
2019 8.43M 0.12%
2018 8.42M 1.39%
2017 8.31M -1.45%
2016 8.43M -0.01%
2015 8.43M 0.00%
2014 8.43M 0.03%
2013 8.43M 0.09%
2012 8.42M 0.03%
2011 8.42M -2.89%
2010 8.67M -0.06%
2009 8.67M 0.70%
2008 8.61M -0.01%
2007 8.61M 0.71%
2006 8.55M 0.83%
2005 8.48M 2.06%
2004 8.31M -4.63%
2003 8.71M 0.00%
2002 8.71M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 894.50M 10,537.41%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.45B 28,978.76%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 20,994.83%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 2.47B 29,297.25%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 1.91B 22,601.87%
CH